logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/05/2025
Bilibili's US stocks rose more than 7%, with Goldman Sachs predicting a 71% year-on-year increase in first-quarter gaming revenue.
Latest
18 m ago
The Invesco QQQ Trust fell 1% after hours, following Moody's downgrade of the US's AAA rating.
18 m ago
Invesco QQQ Trust US stocks fell by 1% in after-hours trading following Moody's downgrade of the United States' Aaa rating.
18 m ago
Chardan Capital: Maintains Century Therapeutics (IPSC.US) rating, adjusted from Buy to Buy rating, target price adjusted from $7.00 to $6.00.
20 m ago
Canadian investment bank group: Maintains IREN (IREN.US) rating, adjusted from buy to buy rating, target price adjusted from $23.00 to $23.00.
22 m ago
Fuguo Bank: Downgrades Inozyme Pharma (INZY.US) rating from buy to hold, with a target price of $4.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.